The Microbiome-Genetics Axis in Autism Spectrum Disorders: A Probiotic Perspective

Area of Science:

• Neurodevelopmental disorders
• Microbiome research
• Gastroenterology

Background:

• Autism spectrum disorder (ASD) is a prevalent neurodevelopmental condition with significant costs and limited effective treatments.
• The gut microbiota's role in ASD, especially for gastrointestinal (GI) symptoms, is increasingly recognized, leading to interest in probiotics.
• Existing clinical studies on probiotics for ASD yield inconsistent results due to methodological variations.

Purpose of the Study:

• To review experimental evidence on gut bacteria and metabolites in relation to autism's complexity.
• To explore the potential of probiotics as a therapeutic strategy for autism spectrum disorder.
• To propose a personalized medicine approach for probiotic use in improving ASD symptoms and quality of life.

Main Methods:

• Literature review of experimental evidence concerning gut bacteria, metabolites, and autism.
• Analysis of phenotypic and etiological complexity and heterogeneity in autism spectrum disorder.
• Discussion of existing clinical trial data on probiotics for autism.

Main Results:

• Evidence suggests a link between specific gut bacteria, their metabolites, and autism.
• Current probiotic studies for autism lack consistency in design and yield inconclusive results.
• Heterogeneity in autism necessitates tailored therapeutic strategies.

Conclusions:

• A personalized medicine approach, selecting specific probiotics based on individual gut microbiota profiles, is proposed for autism treatment.
• Targeting specific gut bacteria and their metabolites may alleviate particular features of autism spectrum disorder.
• Further research is needed to establish definitive probiotic efficacy and optimize personalized treatment protocols for individuals with ASD.